Bugao, Lita L.
HRN: 02-15-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2022
CEFTRIAXONE 1G (VIAL)
11/12/2022
11/18/2022
IVTT
2 G
Once A Day
Community Acquired Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes